NSV Partners III LP, 10% Owner at Ventyx Biosciences, Inc. (VTYX), sold 1,088,492 shares at $35.82 ($4.4M) on 2023-07-07, disclosed to the SEC on 2023-07-19.
Scheduled sale ($4.4M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 964,178 | $0 | 0.0% |
| 2 | $34.99 | 75,686 | $2.6M | 60.2% |
| 3 | $35.82 | 20,718 | $742K | 16.9% |
| 4 | $35.82 | 20,718 | $742K | 16.9% |
| 5 | $36.93 | 3,596 | $133K | 3.0% |
| 6 | $36.93 | 3,596 |
| $133K |
| 3.0% |
| Total | $4.04 avg | 1,088,492 | $4.4M | 100% |
| Filing → |
| VTYX | SELL | 2023-07-06 | $10.5M | — | Filing → |
| VTYX | SELL | 2023-06-16 | $1.8M | — | Filing → |
| VTYX | SELL | 2023-04-25 | $7.7M | — | Filing → |